Insider Selling: Integer Holdings Corp (ITGR) Director Sells 50,559 Shares of Stock
Integer Holdings Corp (NYSE:ITGR) Director Donald J. Spence sold 50,559 shares of the stock in a transaction on Wednesday, March 13th. The shares were sold at an average price of $85.41, for a total value of $4,318,244.19. Following the sale, the director now owns 41,285 shares of the company’s stock, valued at approximately $3,526,151.85. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.
Shares of NYSE:ITGR opened at $85.68 on Friday. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.37 and a current ratio of 2.53. Integer Holdings Corp has a 12-month low of $54.20 and a 12-month high of $92.61. The firm has a market cap of $2.78 billion, a price-to-earnings ratio of 22.55 and a beta of 1.01.
Integer (NYSE:ITGR) last announced its earnings results on Thursday, February 21st. The medical equipment provider reported $1.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.92 by $0.12. Integer had a net margin of 12.88% and a return on equity of 12.56%. The company had revenue of $303.00 million for the quarter, compared to the consensus estimate of $301.25 million. During the same period in the previous year, the business earned $0.96 EPS. The company’s revenue was up .2% on a year-over-year basis. On average, sell-side analysts forecast that Integer Holdings Corp will post 4.2 earnings per share for the current fiscal year.
A number of equities research analysts have recently commented on ITGR shares. Zacks Investment Research upgraded Integer from a “hold” rating to a “strong-buy” rating and set a $101.00 price objective for the company in a research report on Tuesday, February 26th. Royal Bank of Canada increased their price objective on Integer from $84.00 to $92.00 and gave the company a “sector perform” rating in a research report on Monday, February 25th. Finally, TheStreet upgraded Integer from a “c+” rating to a “b-” rating in a research report on Monday, December 17th. One equities research analyst has rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $89.40.
TRADEMARK VIOLATION NOTICE: This story was posted by Watch List News and is the sole property of of Watch List News. If you are accessing this story on another publication, it was copied illegally and republished in violation of U.S. & international trademark & copyright legislation. The legal version of this story can be accessed at https://www.watchlistnews.com/insider-selling-integer-holdings-corp-itgr-director-sells-50559-shares-of-stock/2896211.html.
Integer Holdings Corporation operates as a medical device outsource manufacturer worldwide. It operates in two segments, Medical and Non-Medical. The company offers products for vascular, cardiac surgery, and structural heart diseases; peripheral vascular, neurovascular, urology, and oncology products; and electrophysiology, infusion therapy, and hemodialysis products.
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.